Atherosclerotic Cardiovascular Disease Clinical Trials

ReadTheTrial indexes 2 studies for Atherosclerotic Cardiovascular Disease. The most common development stage is Phase 3 (2 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

2 clinical trials found for Atherosclerotic Cardiovascular Disease.

Pipeline by Phase

PhaseTrialsDistribution
Phase 3 2
100%

Trial Status Breakdown

Trials for Atherosclerotic Cardiovascular Disease

A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

NCT07037433 · RECRUITING · Phase 3

A Phase 2b / 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Combined Dose-Finding and Cardiovascular Outcome Study to Investigate the Efficacy and Safety of CSL300 (Clazakizumab) in Subjects With End Stage Kidney Disease Undergoing Dialysis

NCT05485961 · RECRUITING · Phase 3

Frequently Asked Questions

What clinical trials are available for Atherosclerotic Cardiovascular Disease?

There are 2 clinical trials listed for Atherosclerotic Cardiovascular Disease. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Atherosclerotic Cardiovascular Disease trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Atherosclerotic Cardiovascular Disease trials in?

Current Atherosclerotic Cardiovascular Disease trials are distributed across: Phase 3 (2).

Find More Trials